---
title: "LIU VIVIAN H — Ownership Dossier"
canonical: https://whiteintel.dev/entity/d9db48b5-50cc-5ca3-bd47-e60c063bda49
json: https://whiteintel.dev/api/public/dossier/d9db48b5-50cc-5ca3-bd47-e60c063bda49
identifier: sec:0001203467
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# LIU VIVIAN H

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001203467`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/d9db48b5-50cc-5ca3-bd47-e60c063bda49  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/d9db48b5-50cc-5ca3-bd47-e60c063bda49  

## Ownership & control

### Holdings / subsidiaries

- **APRICUS BIOSCIENCES, INC.** (officer) — https://whiteintel.dev/entity/e7763fb4-4afc-5a47-a077-fda08793cb68
- **AYTU BIOPHARMA, INC** (director) — https://whiteintel.dev/entity/6520f7a2-4c3d-549e-b238-3c4e7551f25e
- **CESCA THERAPEUTICS INC.** (director) — https://whiteintel.dev/entity/4a24b362-8ae0-5e72-a2ae-cf8211e6eddb
- **INNOVUS PHARMACEUTICALS, INC.** (director) — https://whiteintel.dev/entity/dd12304d-86aa-525e-abde-ebc3028d9f4b
- **CESCA THERAPEUTICS INC.** (officer) — https://whiteintel.dev/entity/4a24b362-8ae0-5e72-a2ae-cf8211e6eddb
- **INNOVUS PHARMACEUTICALS, INC.** (officer) — https://whiteintel.dev/entity/dd12304d-86aa-525e-abde-ebc3028d9f4b
- **APRICUS BIOSCIENCES, INC.** (director) — https://whiteintel.dev/entity/e7763fb4-4afc-5a47-a077-fda08793cb68

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **LIU VIVIAN H**. Human view: https://whiteintel.dev/entity/d9db48b5-50cc-5ca3-bd47-e60c063bda49 · Structured JSON: https://whiteintel.dev/api/public/dossier/d9db48b5-50cc-5ca3-bd47-e60c063bda49._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._